Additional research is necessary to elucidate the clinical relevance of our findings, with the aim of developing targeted therapeutic strategies that inhibit cancer progression driven by Ezrin overexpression and restore Ezrin function in pathological conditions characterized by dysfunction of mitochondria metabolism in neuronal cell death. This evidence concerns the gene EZR and cancer.